Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W V Vogel

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Human Antibodies|May 12, 2011
The pharmacokinetics of ¹²⁴I-rituximab in patients with rheumatoid arthritisL Tran, W V Vogel, M Sinaasappel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 6, 2016
The hidden sentinel node in breast cancer: Reevaluating the role of SPECT/CT and tracer reinjectionB Pouw, D Hellingman, M Kieft, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 3, 2014
Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?W L Lodder, W V Vogel, C A Lange, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 4, 2016
Functional Imaging in Radiotherapy in the Netherlands: Availability and Impact on Clinical PracticeW V Vogel, M G E H Lam, F A Pameijer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 8, 2009
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniquesT S Aukema, E J Th Rutgers, W V Vogel, et al.
Clinical and Translational Radiation Oncology|June 8, 2026
Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging modelsC Ceuppens, L A Min, B van Triest, et al.
EJNMMI Research|March 12, 2021
Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodineV Mohan, N M Bruin, M E T Tesselaar, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
First clinical experience with a dedicated PET for hanging breast molecular imagingB B Koolen, T S Aukema, A J González Martínez, et al.
Clinical and Translational Radiation Oncology|April 20, 2026
Oncological outcomes following PSMA PET/CT-guided salvage whole-pelvis radiotherapy for recurrent prostate cancerL G Zuur, A Jansen, S H van der Graaf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyB B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Human Antibodies|May 12, 2011
The pharmacokinetics of ¹²⁴I-rituximab in patients with rheumatoid arthritisL Tran, W V Vogel, M Sinaasappel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 6, 2016
The hidden sentinel node in breast cancer: Reevaluating the role of SPECT/CT and tracer reinjectionB Pouw, D Hellingman, M Kieft, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 3, 2014
Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?W L Lodder, W V Vogel, C A Lange, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 4, 2016
Functional Imaging in Radiotherapy in the Netherlands: Availability and Impact on Clinical PracticeW V Vogel, M G E H Lam, F A Pameijer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 8, 2009
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniquesT S Aukema, E J Th Rutgers, W V Vogel, et al.
Clinical and Translational Radiation Oncology|June 8, 2026
Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging modelsC Ceuppens, L A Min, B van Triest, et al.
EJNMMI Research|March 12, 2021
Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodineV Mohan, N M Bruin, M E T Tesselaar, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
First clinical experience with a dedicated PET for hanging breast molecular imagingB B Koolen, T S Aukema, A J González Martínez, et al.
Clinical and Translational Radiation Oncology|April 20, 2026
Oncological outcomes following PSMA PET/CT-guided salvage whole-pelvis radiotherapy for recurrent prostate cancerL G Zuur, A Jansen, S H van der Graaf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyB B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
Pageof 3